Validation of a Cost-Effective RP-HPLC Method for Quantitative Investigation of Daclatasvir Dihydrochloride in Pharmaceutical Formulations
A well-known direct-acting antiviral (DAA) drug called daclatasvir may be used to treat chronic hepatitis C virus (HCV) infection. Herein, we reported a selective, precise, and a cost-effective analytical method for the measurement of an active pharmaceutical ingredient (API) of daclatasvir dihydroc...
Saved in:
Published in | Journal of chemistry Vol. 2023; pp. 1 - 9 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Hindawi
2023
Hindawi Limited Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!